Dabigatran vs Upadacitinib

Dabigatran vs Upadacitinib: Overview

This comparison examines the pharmacological differences between Dabigatran and Upadacitinib.

Mechanism of Action

Dabigatran: Direct thrombin (Factor IIa) inhibitor.

Upadacitinib: Selective JAK1 inhibitor reducing signaling from cytokines implicated in autoimmune diseases.

Pharmacokinetics

Half-life: Dabigatran — 12-17 hours; Upadacitinib — 9-14 hours.

Chemical Properties

Molecular Formula: Dabigatran — C25H25N7O3; Upadacitinib — C17H19F3N6O.

Molecular Weight: Dabigatran — 471.5100 g/mol; Upadacitinib — 380.3700 g/mol.

Type: Dabigatran — Small molecule; Upadacitinib — Small molecule.